Wird geladen...
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?
Antibiotics have revolutionized the treatment of bacterial infections. However, it is widely held that there is underinvestment in antibiotics research and development relative to the socially optimal level for a number of reasons. In this article, we discuss whether existing health technology asses...
Gespeichert in:
| Veröffentlicht in: | MDM Policy Pract |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935770/ https://ncbi.nlm.nih.gov/pubmed/31910245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319892237 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|